Alvarez-Jimenez, M., Priede, A., Hetrick, S. E., Bendall, S., Killackey, E., Parker, A.G., & Gleeson, J.F. (2012). Risk factors for relapse following treatment for first episode psychosis: A systematic review and meta-analysis of longitudinal studies. Schizophrenia research, 139(1-3), 116-128.
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (DSM-5®). American Psychiatric Pub.
Barut, J.K., Dietrich, M.S., Zanoni, P.A., & Ridner, S.H. (2016). Sense of belonging and hope in the lives of persons with schizophrenia. Archives of psychiatric nursing, 30(2), 178-184.
Chien, W.T., Mui, J., Gray, R., & Cheung, E. (2016). Adherence therapy versus routine psychiatric care for people with schizophrenia spectrum disorders: A randomized controlled trial. BMC psychiatry, 16(1), 42.
Coşkun, E., & Altun, Ö. Ş. (2018). The relationship between the hope levels of patients with schizophrenia and functional recovery. Archives of psychiatric nursing, 32(1), 98-102.
Dewedar, A.E.S., Harfush, S.A., & Gemeay, E.M. (2018). Relationship between insight, self‐stigma and level of hope among patients with schizophrenia. IOSR J Nurs Health Sci (IOSR‐JNHS), 7(5), 15-24.
Eizenberg, M., Ohayon, I.H., Yanos, P.T., Lysaker, P.H., & Roe, D. (2013) Internalized stigma and quality of life among persons with severe mental illness: The mediating roles of self-esteem and hope. Psychiatry research, 208(1), 15–20
Forray, C., & Buller, R. (2017). Challenges and opportunities for the development of new antipsychotic drugs. Biochemical pharmacology,1;143:10-24
Grover, S., & Sahoo, S. (2020). Outcome measurement in schizophrenia: Challenges and barriers. In Schizophrenia Treatment Outcomes (pp. 91-124). Springer, Cham. Book
Gururajan, A., & Malone, D. T. (2016). Does cannabidiol have a role in the treatment of schizophrenia? Schizophrenia Research, 176(2-3), 281-290.
Haddad, P. M., Brain, C., & Scott, J. (2014). Nonadherence with antipsychotic medication in schizophrenia: challenges and management strategies. Patient related outcome measures, 5, 43–62.
Hasson-Ohayon, I., Kravetz, S., Meir, T., & Rozencwaig, S. (2009). Insight into severe mental illness, hope, and quality of life of persons with schizophrenia and schizoaffective disorders. Psychiatry Research, 167(3), 231-238.
Haugan, G., Utvær, B.K.S., & Moksnes, U.K. (2013). The Herth Hope Index: A psychometric study among cognitively intact nursing home patients. Journal of Nursing Measurement, 21(3), 378-400.doi: 10.1891/1061-3749.21.3.378.
Heres, S., Lambert, M., & Vauth, R. (2014). Treatment of early episode in patients with schizophrenia: the role of long acting antipsychotics. European Psychiatry, 29, 1409-1413.
Herth, K. (1992). Abbreviated instrument to measure hope: Development and psychometric evaluation. Journal of Advanced Nursing, 7(10):1251-9.
Karve S, Cleves MA, Helm M, Hudson TJ, West DS, Martin BC.(2009) Good and poor adherence: optimal cut-point for adherence measures using administrative claims data. Curr Med Res Opin. 2009 Sep;25(9):2303-10.
Kavak, F., & Yılmaz, E. (2018). The effect of hope on the treatment adherence of schizophrenia patients. J Turgut Ozal Medic Cent, 25(3), 416-419.
Keshavan, M. S., Diwadkar, V. A., Montrose, D. M., Rajarethinam, R., & Sweeney, J. A. (2005).Premorbid indicators and risk for schizophrenia: A selective review and update. Schizophrenia research, 79(1), 45-57.
Lahera, G., Gálvez, J. L., Sánchez, P., Martínez-Roig, M., Pérez-Fuster, J. V., García-Portilla, P., & Roca, M. (2018). Functional recovery in patients with schizophrenia: Recommendations from a panel of experts. BMC psychiatry, 18(1), 176.
Landeen, J., Pawlick, J., Woodside, H., Kirkpatrick, H., & Byrne, C. (2000). Hope, quality of life, and symptom severity in individuals with schizophrenia. Psychiatric Rehabilitation Journal, 23(4), 364.
Landeen, J., & Seeman, M. V. (2000). Exploring hope in individuals with schizophrenia. International Journal of Psychosocial Rehabilitation, 5, 45-52.
Lappin, J.M., Morgan, C., Chalavi, S., Morgan, K.D., Reinders, A.A.T. S., Fearon, P., & Dazzan, P. (2014). Bilateral hippocampal increase following first-episode psychosis is associated with good clinical, functional and cognitive outcomes. Psychological medicine, 44(6), 1279-1291.
Llorca, Pierre-Michel, Christophe Lançon, SylvieLancrenon,Franck- Jean Bayle, Hervé Caci, Frédéric Rouillon, & PhilipGorwood (2009). The functional remission of general schizophrenia scale: development and validation of a new questionnaire. Schizophrenia Research 113(2), 218-25
Lysaker, P.H., Campbell, K., & Johannesen, J.K. (2005). Hope, awareness of illness, and coping in schizophrenia spectrum disorders: Evidence of an interaction. The Journal of nervous and mental disease, 193(5), 287-292
Potvin, S., Stip, E., Sepehry, A.A., Gendron, A., Bah, R., & Kouassi, E. (2008). Inflammatory cytokine alterations in schizophrenia: A systematic quantitative review. Biological psychiatry, 63(8), 801-808.
Seeman, M. (2019). Does Gender Influence Outcome in Schizophrenia? Psychiatric Quarterly, 90, 173-184.
Tandberg, M., Ueland, T., Sundet, K., Haahr, U., Joa, I., Johannessen, J. O., & McGlashan, T. (2011). Neuro-cognition and occupational functioning in patients with first-episode psychosis: A 2-year follow-up study. Psychiatry Research, 188(3), 334-342.
Turner, N., O'Mahony, P., Hill, M., Fanning, F., Larkin, C., Waddington, J., & Clarke, M. (2015). Work life after psychosis: A detailed examination. Work, 51(1), 143-152.
Van Gestel‐Timmermans, H., Van Den Bogaard, J., Brouwers, E., Herth, K., & Van Nieuwenhuizen, C. (2010). Hope as a determinant of mental health recovery: A psychometric evaluation of the Herth Hope Index‐Dutch version. Scandinavian journal of caring sciences, 24, 67-74.
Uribe, P. M., Bardales, M. C., & Herth, K. (2012). Propiedades psicométricas de la Escala de Esperanza de Herth en español. Revista Iberoamericana de Diagnóstico y Evaluación-e Avaliação Psicológica, 1(33), 127-145.
Uzdil, N., & Tanrıverdi, D. (2015). Effect of psychosocial skills training on functional remission of patients with schizophrenia. Western Journal of Nursing Research, 37(9), 1142-1159.
Wciórka, J., Świtaj, P., & Anczewska, M. (2015). The stages of recovery in relation to the other subjective and objective aspects of psychosis. Psychiatry research, 225(3), 613-618.
Whiteford, H. A., Degenhardt, L., Rehm, J., Baxter, A. J., Ferrari, A. J., Erskine, H. E., & Burstein, R. (2013). Global burden of disease attributable to mental and substance use disorders: Findings from the global burden of disease study 2010. The Lancet, 382(9904), 1575-1586.
Zahran, N., Khalil, A., Okasha, T., & Sadek, H., (2006). Systematic review of Egyptian studies on schizophrenia, psychiatry research, unpublished Master desertion, Faculty of Medicine, Ain Shams University.